|
|
US 7,470,698 B2 |
|
| Adenosine A3 receptor modulators |
| Pier Giovanni Baraldi, Ferrara (Italy); and Pier Andrea Borea, Ferrara (Italy) |
| Assigned to King Pharmaceuticals Research and Development, Inc., Cary, N.C. (US) |
| Filed on Jul. 09, 2007, as Appl. No. 11/774,784. |
| Application 11/774784 is a division of application No. 11/169311, filed on Jun. 27, 2005, granted, now 7,271,171. |
| Application 11/169311 is a division of application No. 10/134219, filed on Apr. 26, 2002, granted, now 6,921,825. |
| Application 10/134219 is a continuation in part of application No. 09/379300, filed on Aug. 23, 1999, granted, now 6,407,236. |
| Application 09/379300 is a continuation in part of application No. 09/154435, filed on Sep. 16, 1998, granted, now 6,448,253. |
| Prior Publication US 2007/0249641 A1, Oct. 25, 2007 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A01N 43/54 (2006.01); A61K 31/505 (2006.01); C07D 239/00 (2006.01); C07D 471/00 (2006.01); C07D 487/00 (2006.01); C07D 491/00 (2006.01)
|
